1. Perspectives on the Ethics of Antibiotic Overuse and on the Implementation of (New) Antibiotics

   • John P. Hays
   • Maria Jose Ruiz-Alvarez
   • the Global AMR Insights Ambassador Network

   Commentary Open access 23 May 2022 Pages: 1315 - 1326

2. Capacity Building in Sub-Saharan Africa as Part of the INTENSE-TBM Project During the COVID-19 Pandemic

   • E. Ariza-Vioque
   • F. Ello
   • INTENSE-TBM Group

   Commentary Open access 29 June 2022 Pages: 1327 - 1341

   

3. Meningococcal Disease and Immunization Activities in Hajj and Umrah Pilgrimage: a review

   • Selim Badur
   • Mansour Khalaf
   • Atef Shibl

   Review Open access 19 May 2022 Pages: 1343 - 1369

   

4. Climate Change and Cascading Risks from Infectious Disease

   • Jan C. Semenza
   • Joacim Rocklöv
   • Kristie L. Ebi

   Review Open access 19 May 2022 Pages: 1371 - 1390

   

5. Immune Response to COVID-19 and mRNA Vaccination in Immunocompromised Individuals: A Narrative Review

   • Norka I. Napuri
   • Daniel Curcio
   • Amit Srivastava

   Review Open access 25 May 2022 Pages: 1391 - 1414

   

6. Laparoscopic Treatment Strategies for Liver Echinococcosis

   • Li Wan
   • Tao Wang
   • Qianjun Yu

   Review Open access 25 June 2022 Pages: 1415 - 1426

   

7. Eliminate Hepatitis C as a Public Health Threat: A Narrative Review of Strategies, Gaps, and Opportunities for China

   • Yuanyuan Song
   • Yuchang Li
   • Jing Sun

   Review Open access 11 July 2022 Pages: 1427 - 1442

8. Cost-Effectiveness of Imipenem/Cilastatin/Relebactam Compared with Colistin in Treatment of Gram-Negative Infections Caused by Carbapenem-Non-Susceptible Organisms

   • Joe Yang
   • Jaesh Naik
   • Ryan James Dillon

   Original Research Open access 25 March 2022 Pages: 1443 - 1457

   

9. Correction to: Cost-Effectiveness of Imipenem/Cilastatin/Relebactam Compared with Colistin in Treatment of Gram-Negative Infections Caused by Carbapenem-Non-Susceptible Organisms

   • Joe Yang
   • Jaesh Naik
   • Ryan James Dillon

   Correction Open access 24 June 2022 Pages: 1459 - 1460

10. Drug Resistance and Risk Factors for Acquisition of Gram-Negative Bacteria and Carbapenem-Resistant Organisms Among Liver Transplant Recipients

    • Xiaoxia Wu
    • Guo Long
    • Qiquan Wan

    Original Research Open access 13 May 2022 Pages: 1461 - 1477

11. Post-Marketing Surveillance of Tetravalent Diphtheria-Tetanus-Acellular Pertussis and Inactivated Poliovirus (DTaP-IPV) Vaccine in South Korea, 2009 to 2015

    • Young June Choe
    • Emmanuel Vidor
    • Christine Manson

    Original Research Open access 14 May 2022 Pages: 1479 - 1492

    

12. Durability and Immunogenicity of Neutralizing Antibodies Response Against Omicron Variants After Three Doses of Subunit SARS-CoV-2 Vaccine MVC-COV1901: An Extension to an Open-Label, Dose-Escalation Phase 1 Study

    • Szu-Min Hsieh
    • Shan-Chwen Chang
    • Chia En Lien

    Original Research Open access 17 May 2022 Pages: 1493 - 1504

    

13. Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective Study

    • Tanya Babich
    • Pontus Naucler
    • Dafna Yahav

    Original Research Open access 25 May 2022 Pages: 1505 - 1519

14. Combined Bacterial Meningitis and Infective Endocarditis: When Should We Search for the Other When Either One is Diagnosed?

    • Guillaume Béraud
    • Sarah Tubiana
    • the COMBAT study group

    Original Research Open access 26 May 2022 Pages: 1521 - 1540

    

15. Integrase Inhibitors Partially Restore Bacterial Translocation, Inflammation and Gut Permeability Induced by HIV Infection: Impact on Gut Microbiota

    • Pablo Villoslada-Blanco
    • Patricia Pérez-Matute
    • José A. Oteo

    Original Research Open access 26 May 2022 Pages: 1541 - 1557

    

16. A Multicenter Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia

    • Giovanni Landoni
    • Lorenzo Piemonti
    • Flavio Mantelli

    Original Research Open access 26 May 2022 Pages: 1559 - 1574

    

17. Efficacy and Safety of Voriconazole Versus Amphotericin B Deoxycholate Induction Treatment for HIV-Associated Talaromycosis: A Prospective Multicenter Cohort Study in China

    • Yihong Zhou
    • Yuanyuan Qin
    • Yaokai Chen

    Original Research Open access 11 June 2022 Pages: 1575 - 1590

    

18. Does Monitoring Total and Free Polymyxin B1 Plasma Concentrations Predict Polymyxin B-Induced Nephrotoxicity? A Retrospective Study in Critically Ill Patients

    • Yang Deng
    • Jun-Yuan Gu
    • Gui-Ying Xiao

    Original Research Open access 11 June 2022 Pages: 1591 - 1608

    

19. Multicenter Registry of Patients Receiving Systemic Mold-Active Triazoles for the Management of Invasive Fungal Infections

    • L. Ostrosky-Zeichner
    • M. H. Nguyen
    • G. R. Thompson III

    Original Research Open access 18 June 2022 Pages: 1609 - 1629

    

20. Clinical Characteristics of Chlamydia psittaci Pneumonia Infection in Central South China

    • Min Yang
    • Dan-Hui Yang
    • Hong Luo

    Original Research Open access 20 June 2022 Pages: 1631 - 1647

    

21. Linezolid vs Vancomycin in Induced Thrombocytopenia

    • Dimah Al-Harbi
    • Abdulrahman Alturaiki
    • Laila Carolina Abu Esba

    Original Research Open access 21 June 2022 Pages: 1649 - 1660

22. Effectiveness and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir as a Hepatitis C Virus Infection Salvage Therapy in the Real World: A Systematic Review and Meta-analysis

    • Jing Xie
    • Bin Xu
    • Wei Liu

    Original Research Open access 24 June 2022 Pages: 1661 - 1682

    

23. Cost-Effectiveness of Newly Recommended Pneumococcal Vaccination Strategies in Older Underserved Minority Adults in the USA

    • Kenneth J. Smith
    • Angela R. Wateska
    • Richard K. Zimmerman

    Original Research Open access 13 July 2022 Pages: 1683 - 1693

    

24. Explainable Machine-Learning Model for Prediction of In-Hospital Mortality in Septic Patients Requiring Intensive Care Unit Readmission

    • Chang Hu
    • Lu Li
    • Zhiyong Peng

    Original Research Open access 14 July 2022 Pages: 1695 - 1713

    

25. Real-World, Multicenter Case Series of Patients Treated with Oral Omadacycline for Resistant Gram-Negative Pathogens

    • Taylor Morrisette
    • Sara Alosaimy
    • Michael J. Rybak

    Brief Report Open access 14 May 2022 Pages: 1715 - 1723

26. Genomic Epidemiology of MBL-Producing Pseudomonas putida Group Isolates in Poland

    • Paweł Urbanowicz
    • Radosław Izdebski
    • Marek Gniadkowski

    Brief Report Open access 10 June 2022 Pages: 1725 - 1740

    

27. Potential of Continuous Local Antibiotic Perfusion Therapy for Fracture-Related Infections

    • Kenji Kosugi
    • Yukichi Zenke
    • Akinori Sakai

    Case Series Open access 21 May 2022 Pages: 1741 - 1755

    

28. Letter to the Editor Regarding: “Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants”

    • Jorge A. Gomez
    • Javier Nieto Guevara
    • Edwin Rodriguez

    Letter Open access 16 May 2022 Pages: 1757 - 1761

29. Response to Gomez et al.’s Letter to the Editor Regarding: “Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants”

    • Johnna Perdrizet
    • Emily Horn
    • Anna Ong-Lim

    Letter Open access 16 May 2022 Pages: 1763 - 1765

30. Correction to: Early Transfusion of Convalescent Plasma Improves the Clinical Outcome in Severe SARS-CoV2 Infection

    • Eszter Fodor
    • Veronika Müller
    • Zsombor Lacza

    Correction Open access 16 May 2022 Pages: 1767 - 1768